Recover, Re-form, Re-purposeI am interested
Developed Disruptive Innovation to Recover, Reform and Repurpose Waste
Environmental Sustainability & Commercial Viability
Provides an Affordable Global Solution to a Global Problem
Business Model that Generates High Revenue and Profit Potential
Pioneering innovative solutions
To recover valuable resources from waste
A unique competitive advantage
Recovering, re-forming, and re-purposing waste materials
The ARC Process™ consists of processes that are used to recover, re-form and re-purpose all mixed unsegregated waste components.
From the recovery of nutrients from the organic waste components to the conversion of plastic waste into hydrogen and industrial carbon, this technology forms the foundation for real solutions to global waste challenges.
The technology utilises an innovative approach to waste recovery and upcycling and is protected under a patent pending.
Strong business model that meets the 3 pillars of sustainability – People, Planet, Profit.
Collaborations with 3 universities on further research that will enhance value.
Three pending grant applications with both the NSW and Federal Governments on a research grant for hydrogen recovery as well as commercialisation of the ARC process for recovering waste plastic
Arc Ento Tech was incorporated in Australia in Feb 2020 after conducting proof of concept trials overseas. Its focus is on the use of insects to recover nutrients from organic waste and combining with a novel approach to recovering and converting all plastic waste into viable commercial products.
The company has established both markets and clients for the sale and supply of waste, as well as waste derived products and is ready to commercialise the first set of plants.
This is leading edge technology that will change the landscape of waste processing around the world. Following on from the demonstration and initial start-up plants there are already discussions to construct and operate at least seven full scale plants as early as 2024 with overseas expansion following shortly after.
Raising up to A$10M with a pre-money valuation of A$36M.
The minimum subscription is A$7M but up to A$10M maximum.
The company has engaged PrimaryMarkets to establish a private trading hub to facilitate Secondary Trading in 2023.
Post-2025 Arc Ento Tech intends to list on the ASX.
Use of funds
A$6.5MConstruction of 6 ARC Process micro plants for local food processors
A$2.5MConstruction of 2 demo ARC process MSW, Bio-solids & FOGO plants
A$1MMarketing, administration, and compliance costs
Want to learn more?
Fill in the expression of interest form below
Speak to our investment team today+61 2 9993 4475